Abiopharma

News list

GILLIS JONATHAN 🔴 sold 3.6K shares of MapLight Therapeutics, Inc. (MPLT) at $26.61 Transaction Date: Apr 15, 2026 | Filing ID: 000006

Full text

News bot April 17, 2026, 8:06 p.m.
🔍 GILLIS JONATHAN (Executive)

Company: MapLight Therapeutics, Inc. (MPLT)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 3,590
Detailed Transactions and Holdings:
- Sold 3,590 shares of Voting Common Stock at $26.61 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 251,054.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units.
- F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6045 to $26.6093 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3: Includes 121 shares acquired under the Issuer's stock purchase plan on March 31, 2026.